AM Best


AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries


CONTACTS:

Louis Silvers
Senior Financial Analyst
+1 908 882 2316
louis.silvers@ambest.com

Kate Steffanelli
Associate Director
+1 908 882 2337
kate.steffanelli@ambest.com
Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

FOR IMMEDIATE RELEASE

OLDWICK - NOVEMBER 18, 2026 04:05 PM (EST)
AM Best has affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa+” (Superior) of Massachusetts Mutual Life Insurance Company (MassMutual) (domiciled in Springfield, MA) and its life/health subsidiaries, C.M. Life Insurance Company, MML Bay State Life Insurance Company, MassMutual Ascend Life Insurance Company (MassMutual Ascend) and Annuity Investors Life Insurance Company (ALIC) (Cincinnati, OH).

Concurrently, AM Best has affirmed the Long-Term Issue Credit Ratings (Long-Term IR) of “aa-” (Superior) on the surplus notes of MassMutual and “aa+” (Superior) on notes issued under the funding agreement-backed securities programs of MassMutual Global Funding II.

Additionally, AM Best has affirmed the FSR of B++ (Good) and the Long-Term ICR of “bbb+” (Good) of Manhattan National Life Insurance Company (Manhattan Life) (Cincinnati, OH).  The outlook of all these Credit Ratings (ratings) is stable. (See below for a detailed listing of the Long-Term IRs and Short-Term Issue Credit Rating [Short-Term IR]).

The ratings reflect MassMutual’s balance sheet strength, which AM Best assesses as strongest, as well as its strong operating performance, very favorable business profile and very strong enterprise risk management (ERM).

MassMutual’s risk-adjusted capitalization, is at the very strong level, as measured by Best’s Capital Adequacy Ratio (BCAR), which reflects the company’s ability to support its insurance, investment and business risks. The company’s capital levels have increased over the years, driven by earnings growth and strong investment income. The BCAR is forecasted to strengthen in 2026, driven by the reinsurance of the Universal Life business, as well as a cash infusion from repurchase of its preferred shares from Invesco Ltd. [NYSE: IVZ].

MassMutual continues to hold elevated investment allocations in private placements, below investment-grade bonds and Schedule BA assets. However, these have been effectively managed through MassMutual’s Barings investment subsidiary and are monitored with good asset-liability management capabilities, as well as robust stress testing. Financial flexibility is supported by the organization’s proven ability to access the capital markets. The company maintains sufficient liquidity to meet sudden, unanticipated needs, and this is monitored and stress tested on a regular basis. MassMutual’s leverage ratios remain well within AM Best’s guidelines.

MassMutual continues to hold leading market positions in life insurance, fixed and fixed-indexed annuities, and institutional insurance products and asset management. The company’s business profile has shifted in recent years toward whole life, fixed annuity, pension risk transfer and institutional asset management. AM Best assesses MassMutual’s ERM program’s capabilities as very strong relative to its risk profile. AM Best expects MassMutual to continue investing in technology across its distribution platforms and enhance its ERM and innovation programs, going forward.

The ratings reflect Manhattan Life’s balance sheet strength, which AM Best assesses as very strong, as well as its marginal operating performance, limited business profile and appropriate ERM.

Manhattan Life’s book of business is in run-off mode, with most of its liabilities reinsured through highly rated reinsurers. The company’s risk-adjusted capitalization, as measured by BCAR, is assessed at the strongest level and has increased in the last year driven by declining liabilities. The parent company has previously demonstrated that it will support the life company with capital contributions, when needed. Manhattan Life’s earnings trends have been volatile, and a small increase in life claims can have a material impact on results. Partially mitigating factors include its modest portion of business relative to the enterprise and the support of its parent, as well as a long-term trend of declining reserves due to the nature of the run-off company.

The following Long-Term IRs have been assigned with stable outlooks:

MassMutual Global Funding II—“aa+” (Superior) program rating

- “aa+” (Superior) to the $700 million, 4.8% senior secured medium-term notes, due 2029

- “aa+” (Superior) to the $300 million, 0.72% senior secured medium-term notes, due 2029

- “aa+” (Superior) to the $700 million, 5.6% senior secured medium-term notes, due 2031

- “aa+” (Superior) to the GBP 450 million, 5.25% senior secured medium-term notes, due 2033

- “aa+” (Superior) to the CAD 550 million, 4.497% senior secured medium-term notes, due 2033

- “aa+” (Superior) to the CHF 225 million, 1.377% senior secured medium-term notes, due 2033

The following Long-Term IRs have been affirmed with stable outlooks:

Massachusetts Mutual Life Insurance Company—

- “aa-” (Superior) on $250 million, 5.625% surplus notes, due 2033 (of which $193 million remains outstanding)

- “aa-” (Superior) on $750 million, 8.875% surplus notes, due 2039 (of which $130 million remains outstanding)

- “aa-” (Superior) on $400 million, 5.375% surplus notes, due 2041 (of which $263 million remains

outstanding)

- “aa-” (Superior) on $500 million, 4.5% surplus notes, due 2065 (of which $258 million remains

outstanding)

- “aa-” (Superior) on $475 million, 4.9% surplus notes, due 2077

- “aa-” (Superior) on $838.5 million, 3.729% surplus notes, due 2070

- “aa-” (Superior) on $700 million, 3.375% surplus notes, due 2050

- “aa-” (Superior) on $500 million, 5.672% surplus notes, due 2052

- “aa-” (Superior) on $1 billion, 5.95% surplus notes, due 2056

- “aa-” (Superior) on $675 million, 3.2% surplus notes, due 2061

- “aa-” (Superior) on $800 million, 5.077% surplus notes, due 2069

MassMutual Global Funding II—“aa+” (Superior) program rating

- “aa+” (Superior) on all outstanding notes issued under the program

The following Short-Term IR has been affirmed:

Massachusetts Mutual Life Insurance Company—

- AMB-1+ (Strongest) on commercial paper program

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings (BCR), Best’s Performance Assessments (PA), Best’s Preliminary Credit Assessments (PCA) and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City.




Related Companies

For information about each company, including the Best's Credit Reports, group members (where applicable) and news stories, click on the company name. An additional purchase may be required.